Single-Base Resolution Method of 5-hmC in Biology
Single-Base Resolution Method of 5-hmC in Biology
批准号:
8252069
负责人:
Shuang Chang
金额:
$21.22万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2014-07-31
关键词:
AddressAffinityAgingAntibodiesBiologicalBiological MarkersBiological ProcessBiological SciencesBiologyBiotinCellsChemicalsCommunitiesCytosineDNADetectionDevelopmentDigestionDiseaseDisease MarkerEpigenetic ProcessExodeoxyribonuclease IIIExonucleaseFutureGene ExpressionGenomeGenomic ImprintingGenomicsGlucoseGlucosyltransferaseHumanHypoxiaInvestigationLabelLaboratory ResearchLigationLocationMaintenanceMalignant NeoplasmsMammalian CellMedicineMethodsModificationMusNeurodegenerative DisordersPhasePlayPositioning AttributePrimer ExtensionReactionReagentRegulationResearchResearch PersonnelResolutionRoleSmall Business Innovation Research GrantTechnologyTestingTissuesWorkX Inactivationangiogenesisbasecancer cellembryonic stem cellfunctional groupglycosylationhuman diseaseleukemiamammalian genomenew technologynext generationsodium bisulfitestemsuccesstoolzygote
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): 5-Hydroxymethylcytosine (5-hmC) is a newly identified base modification in mammalian genomic DNA. Because current sequencing methods cannot differentiate 5-meC from 5-hmC, the immediate challenge is to develop robust methods to ascertain the positions of 5-hmC within the mammalian genome, a problem best addressed by adapting a new chemical labeling technology that we have developed. We show that the hydroxymethyl group of 5-hmC can be selectively labeled with chemically modified glucoses using 2-glucosyltransferase (2GT). This glycosylation offers a strategy of installing functional groups such as biotin onto 5-hmC. In this way, we can affinity capture DNA fragments containing the modified 5-hmC and develop sequencing methods to determine the precise locations of 5-hmC. Building on our early successes we propose to develop single base-resolution detection and sequencing methods to reveal the distribution of 5-hmC in mammalian genomes. We propose two different approaches, both utilizing the selective chemical labeling strategy we have developed. In one approach, we will label 5-hmC with bulky groups to hinder ligation and linear PCR reactions, thus achieving single base-resolution detection of 5-hmC. The linear PCR approach can be adapted into the next generation Solexa sequencing to perform high throughput determination of 5-hmC in mammalian genomes. In an alternative approach, we wil develop an exonuclease digestion blockage method that detects modified 5-hmC at 3' end of undigested DNA fragments using the next generation Solexa sequencing; we have already shown that the chemically modified 5-hmC blocks exonuclease III digestion at 3' end of the modified 5-hmC. The new technologies proposed in this SBIR application not only have great values as commercial research reagents, but also promise to efficiently discover and detect 5-hmC as biomarkers in various human diseases. !
PUBLIC HEALTH RELEVANCE: 5-Hydroxymethylcytosine (5-hmC) is a newly discovered base modification surprisingly abundant in the genomic DNAs of certain mammalian tissues and cells. The proposed work will develop efficient chemical labeling methods to perform single base-resolution detection and sequencing of 5-hmC in genomic DNAs. The success of the proposed work will enable the researchers to reveal the fundamental role(s) of 5-hmC in biology and develop potential disease markers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金